Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Keld Per Kjeldsen
The symposium was jointly organized by ESC and the European Renal Association. The common origin of cardiovascular disease and CKD was reviewed. It was discussed how the treatment of one is equal to the treatment of the other, with the need to add specific therapy when renal function decrease is advanced. The risk of Renin-Angiotensin-Aldosterone-System suppression leading to a poorer treatment was emphasised. The importance of maintaining plasma-potassium in upper normal range was discussed. The relationship between blood pressure (BP) and CKD, both in diabetic and non-diabetic patients was reviewed. Elevated BP particularly during the night correlates with an increased renal damage and more albuminuria, particularly in diabetics. The control of BP must contemplate duration of 24 hours. Patients in dialysis differ from those with CKD due to the fluctuations in volume and electrolytes interdialysis which is accompanied by a poor prognosis if excessive. In heart failure, hypotension is a poor prognostic index in dialysis patients. An important conclusion was that in order to protect the kidney the earlier the therapy the better the outcome. Also, it should be noted that one level of BP does not fit with every CKD patient. The relation between chronic heart failure and CKD was reviewed. It was demonstrated that the association is very frequent and complicates the therapy of these patients due to adverse effects of the drugs or a poor response to them. The Guidelines of ESC and ACC on patients with HF and CKD were found to be almost similar. Treatment in patients with advanced CKD is particularly difficult – e.g. in elderly hypotensive patients - and complicates the entrance into a dialysis program. Acute coronary syndrome and CKD was reviewed. The association is frequent and it was pointed out that these patients are frequently undertreated for their coronary syndrome both pharmacologically and interventionally. Maybe, thrombolysis may be superior to Percoutaneous Coronary Intervention in CKD. In general, there were advocated for increased attention to heart patients with CKD in trials, in guidelines and in clinical practice.
Does the presence of chronic kidney disease modify the advice of guidelines?
© 2017 European Society of Cardiology. All rights reserved